Code is covered without prior authorization (high confidence)
Medicare Pricing
Work RVU
0.00
Facility
N/A
Non-Facility
N/A
Documentation Required
Clinical documentation of clinically significant allergic symptoms and that testing is part of a complete diagnostic evaluation.
Documentation from the licensed practitioner confirming scope-of-practice and justification for selected antigens (i.e., likelihood of member exposure).
Record of number/units of tests performed to demonstrate compliance with state-specific unit limits or applicable NCCI MUE limits.
Documentation of negative percutaneous (skin prick) test results when performing intracutaneous (intradermal) testing.
Key Coverage Criteria
Allergy testing to determine immunologic sensitivity for immediate (IgE-mediated) hypersensitivity.
Allergy testing to determine immunologic sensitivity for delayed (cell-mediated) hypersensitivity.
Allergen immunotherapy (repeated administration of specific allergens) for patients with IgE-mediated allergic conditions to reduce allergic symptoms and inflammatory reactions.
Allergy testing is medically necessary for members with clinically significant allergic symptoms as part of a complete diagnostic evaluation by a licensed practitioner acting within their scope.
Testing should include only antigens that the member is reasonably likely to be exposed to.
Percutaneous testing (scratch, puncture, prick) is indicated to evaluate suspected offending allergens such as pollen, molds, mites, dust, feathers, animal fur/dander, venoms, foods, or drugs (CPT 95004, 95017, 95018).